Healthcare - Biotechnology - NASDAQ - BM
$ 21.29
-2.38 %
$ 1.54 B
Market Cap
-177.42
P/E
CASH FLOW STATEMENT
13.3 M
OPERATING CASH FLOW
-29.6 M
INVESTING CASH FLOW
1.5 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Kiniksa Pharmaceuticals, Ltd.
| Net Income | 14.1 M |
| Depreciation & Amortization | 2.34 M |
| Capital Expenditures | -130 K |
| Stock-Based Compensation | 27.1 M |
| Change in Working Capital | 1.35 M |
| Others | 13.6 M |
| Free Cash Flow | 13.2 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | |
|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||
| Net Income | 14.1 | 183.4 | (157.9) | (161.4) | (161.9) | (103.2) | (64.9) | (24.0) |
| Depreciation & Amortization | 2.3 | 2.4 | 2.4 | 2.4 | 2.1 | 0.3 | 28 K | 22 K |
| Deferred Income Tax | (33.8) | (185.5) | 11 K | 4.4 | (3.2) | (1.0) | (0.2) | 46 K |
| Stock Based Compensation | 27.1 | 25.1 | 25.2 | 20.9 | 15.1 | 5.7 | 0.9 | 0.4 |
| Other Operating Activities | 2.2 | 3.0 | 3.4 | 1.5 | 6.5 | (1.1) | 53 K | 0.3 |
| Change in Working Capital | 1.4 | (22.6) | 0.7 | (4.3) | (17.0) | 18.3 | 13.9 | 1.8 |
| Cash From Operations | 13.3 | 5.8 | (126.3) | (136.5) | (158.4) | (81.0) | (50.2) | (21.9) |
| INVESTING CASH FLOW | ||||||||
| Capital Expenditures | (0.1) | (0.1) | (20.4) | (0.3) | (3.2) | (5.3) | 69 K | 3 K |
| Other Items | (29.4) | (8.0) | 149.1 | (23.2) | 52.4 | (233.9) | 0 | 0 |
| Cash From Investing Activities | (29.6) | (8.1) | 128.6 | (23.4) | 49.2 | (239.2) | 69 K | 3 K |
| FINANCING CASH FLOW | ||||||||
| Common Stock Repurchased | (2.2) | (0.9) | 5.9 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 3.7 | 3.4 | 5.9 | (1.1) | 1.0 | 187.5 | 39.9 | 42.5 |
| Cash From Financing Activities | 1.5 | 2.5 | 5.9 | 227.1 | 84.1 | 346.7 | 39.9 | 42.5 |
| CHANGE IN CASH | ||||||||
| Net Change In Cash | (14.8) | 0.2 | 8.2 | 67.1 | (25.0) | 26.5 | (10.4) | 20.6 |
| FREE CASH FLOW | ||||||||
| Free Cash Flow | 13.2 | 5.7 | (146.7) | (136.8) | (161.6) | (86.3) | (50.3) | (21.9) |